AHR and Alzheimer disease: FICZ, a highly potent endogenous AhR ligand, has been shown to exert anti-inflammatory effects by downregulating FcεRI and upregulating indoleamine 2,3-dioxygenase in Langerhans cells, suggesting a feedback mechanism that could mitigate allergen-induced inflammation in AD [49].